Filters
Also try searching for:
*ERF
on 12 Jul 2024
GLAXO GROUP LIMITED
2226826 · 18 Oct 2022
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and Leiomyoma; pharmaceutical preparations and substances for use in urology, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines for human use; pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders.
Pharmaceutical preparations for use as anti-infectives; pharmaceutical...
on 20 Nov 2024
Glaxo Group Limited
2226817 · 18 Oct 2022
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives, pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus, pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders, pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders, pharmaceutical preparations for the treatment of atherosclerosis, pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management, pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders, pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders, pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis, pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood, pharmaceutical preparations for the treatment of musculoskeletal diseases, pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis, pharmaceutical preparations for use in ophthalmology, pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, pharmaceutical preparations for the treatment of hormonal disorders, pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders, pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders, pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, thyroid hormone preparations, pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders, pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and Leiomyoma, pharmaceutical preparations and substances for use in urology, pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, pharmaceutical preparations for the treatment of hepatological diseases and disorders, pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis, pharmaceutical preparations for the treatment of alopecia and androgenic alopecia, pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses, pharmaceutical preparations for the treatment of malaria, pharmaceutical preparations for the treatment of tuberculosis, Allergy medications, Vaccines for human use, pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia, pharmaceutical preparations for the treatment of muscular dystrophy, pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders, none of the aforementioned goods being for use in the treatment of conditions or symptoms related to fertility, contraception or human reproduction.
Pharmaceutical preparations for use as anti-infectives, pharmaceutical...
on 24 Sep 2010
1031540 ALBERTA LTD.
1365912 · 02 Oct 2007
035
Class 035
Advertising, Business & Retail Services
Online retail store services featuring digital musical content, namely providing downloadable pre-recorded music via the internet; online retail store services featuring musical content, namely, streaming of audio material on the internet; information services, namely providing information in the field of music and musical performances via the internet.
041
Class 041
Education and Entertainment Services
Online retail store services featuring digital audio and video content, namely providing downloadable pre-recorded audio and video material via the internet; online retail store services featuring audio and video content, namely, streaming of audio and video material on the internet; retail sale of music and music-related merchandise; marketing services, namely, arranging for the distribution of pre-recorded music of others through retail store outlets and through online retail stores.
Online retail store services featuring digital musical content, namely...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
1031540 alberta ltd. (1)
Glaxo group limited (1)
Glaxo group limited (1)
Kimberly-clark of canada limited (1)
Categories
Class 5 (2)
Class 16 (1)
Class 35 (1)
Class 41 (1)
Correspondents
Borden ladner gervais llp (2)
Clark wilson llp (1)
Image Search
Drag and drop or upload to search any image
End of search results
Page 1 of 1